BRIEF-EU Medicines Agency recommends approval of two new cancer drugs
July 22, 2016 at 07:21 AM EDT
* Recommends approval of Exelixis Inc'S cabozantinib to treat advanced renal cell carcinoma
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.